DNP
2,4-Dinitrophenol
Industrial mitochondrial uncoupler; extremely hazardous with documented fatalities. For harm-reduction reference only.
Key takeaways
- Mitochondrial uncoupler from the 1930s diet-pill era; banned, with documented fatalities.
- ~89-hour half-life means doses accumulate fast across consecutive days.
- No antidote exists; hyperthermia from overdose is frequently fatal.
- Harm-reduction reference only; no safe dose has ever been established.
Reported dosing protocols
Protocols reported in research literature and clinic/community use β informational context, not a dosing recommendation.
| Use case | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Weight loss (community, dangerous) | 50β200 mg | Oral | Once daily | Short runs only (days to ~2 weeks) |
Pharmacokinetic summary
- Model tier
- Advanced (tΒ½ + Cmax + Tmax + F)
- Half-life
- 3.7 days
- Cmax
- 0.04166666667 mcg/mL
- Tmax
- 0.0 days
- Bioavailability
- 100%
- Typical dose
- 50β200 mg
Harm reduction
- Aromatizes
- No
- Hepatotoxicity
- severe
β DNP is exceptionally dangerous β narrow therapeutic window, documented fatalities. This entry is for harm reduction only.
Frequently asked questions
Why is DNP so dangerous compared to other fat-loss drugs?
It raises metabolic rate by wasting energy as heat, with no feedback brake. As blood levels climb, heat production outruns the body's ability to shed it, causing fatal hyperthermia. The dose-response is steep and varies between individuals.
Is there an antidote to DNP poisoning?
No. Treatment is supportive only: aggressive cooling, fluids, and ICU care. Survival depends on the dose taken and how quickly cooling starts, which is why documented case reports so often end in death.
Why does half-life matter so much with DNP?
With a roughly 89-hour half-life, most of each dose is still active when the next is taken, so blood levels accumulate far beyond what a single dose produces. People misjudge this and redose into toxic territory.
References
- PMC DNP PK β Estimates from Fig. 4. No good bioavailability source.
- 2,4-Dinitrophenol as medicine (Cells 2019) β Entry's PK source; history and pharmacology of DNP.
- Grundlingh et al., J Med Toxicol 2011 β Toxicity review: acute poisoning, fatalities, and the narrow margin of safety.
Related compounds
Comments
Loading commentsβ¦